- Filed
- Feb 16, 2021 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Feb 10, 2021 | 91.01M sh |
| Capex | Q1 2020 · Oct 31, 2019 | $77.77K |
| Capex | Q1 2020 · Oct 31, 2018 | $20.57K |
| Operating Cash Flow | Q1 2020 · Oct 31, 2019 | −$1.96M |
| Operating Cash Flow | Q1 2020 · Oct 31, 2018 | −$357.03K |
| Cash And Equivalents | Q1 2020 · Oct 31, 2019 | $12.9M |
| Cash And Equivalents | Q1 2020 · Jul 31, 2019 | $14.92M |
| Cash And Equivalents | Q1 2020 · Oct 31, 2018 | $1.99M |
| Cash And Equivalents | Q1 2020 · Jul 31, 2018 | $1.06M |
| Stockholders Equity restated | Q1 2020 · Oct 31, 2019 | $10.9M |
| Stockholders Equity restated | Q1 2020 · Jul 31, 2019 | $14.45M |
| Current Liabilities restated | Q1 2020 · Oct 31, 2019 | $10.84M |
| Current Liabilities restated | Q1 2020 · Jul 31, 2019 | $9.04M |
| Total Liabilities | Q1 2020 · Oct 31, 2019 | $11.07M |
| Total Liabilities | Q1 2020 · Jul 31, 2019 | $9.05M |
| Current Assets restated | Q1 2020 · Oct 31, 2019 | $17.23M |
| Current Assets restated | Q1 2020 · Jul 31, 2019 | $19.12M |
| Total Assets restated | Q1 2020 · Oct 31, 2019 | $22.02M |
| Total Assets restated | Q1 2020 · Jul 31, 2019 | $23.55M |
| Sga Expense | Q1 2020 · Oct 31, 2019 | $3.73M |
| Sga Expense | Q1 2020 · Oct 31, 2018 | $238.31K |
| Net Income restated | Q1 2020 · Oct 31, 2019 | −$3.55M |
| Net Income | Q1 2020 · Oct 31, 2018 | −$335.46K |
| Operating Income restated | Q1 2020 · Oct 31, 2019 | −$3.62M |
| Operating Income | Q1 2020 · Oct 31, 2018 | −$335.6K |
| Gross Profit restated | Q1 2020 · Oct 31, 2019 | $1.48M |
| Gross Profit restated | Q1 2020 · Oct 31, 2018 | $625.25K |
| Cost Of Revenue restated | Q1 2020 · Oct 31, 2019 | $1.74M |
| Cost Of Revenue restated | Q1 2020 · Oct 31, 2018 | $117.5K |